China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY) Stock Short Interest Report for September

China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 155 shares, a decline of 47.5% from the September 15th total of 295 shares. Based on an average daily trading volume, of 388 shares, the days-to-cover ratio is presently 0.4 days.

China Shineway Pharmaceutical Group Price Performance

CSWYY stock remained flat at C$16.79 during midday trading on Thursday. The company’s stock had a trading volume of 212 shares, compared to its average volume of 604. The company’s fifty day simple moving average is C$19.79 and its 200-day simple moving average is C$19.25. China Shineway Pharmaceutical Group has a one year low of C$16.79 and a one year high of C$22.23.

About China Shineway Pharmaceutical Group

(Get Free Report)

China Shineway Pharmaceutical Group Ltd. is a Chinese pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicines and related healthcare products. Its portfolio includes prescription and over-the-counter medicines in forms such as injections, capsules, tablets, oral liquids and granules.

The company’s products address a range of therapeutic areas, including respiratory, cardiovascular, digestive and gynecological conditions. Its better-known traditional Chinese medicine products include Qingkailing and Shuanghuanglian formulations, which are marketed in multiple dosage forms.

China Shineway is headquartered in Shijiazhuang, Hebei Province, China, and primarily serves the Chinese pharmaceutical market through hospitals, pharmacies and other healthcare distribution channels.

Further Reading

Receive News & Ratings for China Shineway Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Shineway Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.